How do I buy shares of MediPharm Labs? Shares of MEDIF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Full Answer
What are analysts'target prices for medipharm labs'stock?
3 brokers have issued twelve-month target prices for MediPharm Labs' stock. Their forecasts range from C$0.35 to C$0.50. On average, they expect MediPharm Labs' share price to reach C$0.40 in the next twelve months. This suggests a possible upside of 128.6% from the stock's current price.
Is medipharm labs (Medi) stock a buy or sell?
MediPharm Labs has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 3 hold ratings, and no sell ratings. According to analysts' consensus price target of C$0.40, MediPharm Labs has a forecasted upside of 128.6% from its current price of C$0.18.
What are medipharm labs'price targets for the next year?
6 brokerages have issued 12 month price targets for MediPharm Labs' shares. Their forecasts range from $1.00 to $1.75. On average, they expect MediPharm Labs' stock price to reach $1.38 in the next year. This suggests a possible upside of 271.6% from the stock's current price.
What is the symbol for medipharm labs?
MediPharm Labs trades on the Toronto Stock Exchange (TSX) under the ticker symbol "LABS." How do I buy shares of MediPharm Labs? Shares of LABS and other Canadian stocks can be purchased through an online brokerage account.
Should I buy MediPharm Labs stock?
There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" MediPharm Labs stock.
Why is MediPharm Labs stock dropping?
MediPharm shares fell more than 90% since reaching a peak in 2019 as a result of a total collapse in its revenue in just one year. The company lost the majority of its wholesale revenue as the market became oversupplied, and its white label business was inadequate.
Will MediPharm stock go up?
MediPharm Labs Corp. quote is equal to 3.520 USD at 2022-06-21. Based on our forecasts, a long-term increase is expected, the "MLCPF" stock price prognosis for 2024-04-03 is 16.917 USD. With a 5-year investment, the revenue is expected to be around +380.59%.
Is Medif a good buy?
According to the issued ratings of 2 analysts in the last year, the consensus rating for MediPharm Labs stock is Buy based on the current 1 hold rating and 1 buy rating for MEDIFthe . Learn more on MEDIF's analyst rating history.
Should I buy or sell MediPharm Labs stock right now?
2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for MediPharm Labs in the last twelve months. There are curr...
What is MediPharm Labs' stock price forecast for 2022?
2 brokers have issued 1 year target prices for MediPharm Labs' stock. Their forecasts range from $0.10 to $0.25. On average, they anticipate MediPh...
How has MediPharm Labs' stock performed in 2022?
MediPharm Labs' stock was trading at $0.1460 on January 1st, 2022. Since then, MEDIF shares have decreased by 59.6% and is now trading at $0.0590....
Who are MediPharm Labs' key executives?
MediPharm Labs' management team includes the following people: Mr. Keith Strachan , Co-Founder & Pres Mr. Greg Hunter , Chief Financial Officer...
Who are some of MediPharm Labs' key competitors?
Some companies that are related to MediPharm Labs include Abacus Health Products (ABAHF) , Acreage (ACRGF) , Alliance Growers (ACGWF) , Althea...
What is MediPharm Labs' stock symbol?
MediPharm Labs trades on the OTCMKTS under the ticker symbol "MEDIF."
How do I buy shares of MediPharm Labs?
Shares of MEDIF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBu...
What is MediPharm Labs' stock price today?
One share of MEDIF stock can currently be purchased for approximately $0.06.
How many employees does MediPharm Labs have?
MediPharm Labs employs 204 workers across the globe.
Should I buy or sell MediPharm Labs stock right now?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MediPharm Labs in the last year. There are currently 1 buy rating for the...
What is MediPharm Labs' stock price forecast for 2022?
1 Wall Street research analysts have issued 12-month price objectives for MediPharm Labs' stock. Their LABS stock forecasts range from C$0.20 to C$...
How has MediPharm Labs' stock price performed in 2022?
MediPharm Labs' stock was trading at C$0.19 at the start of the year. Since then, LABS shares have decreased by 62.2% and is now trading at C$0.07....
When is MediPharm Labs' next earnings date?
MediPharm Labs is scheduled to release its next quarterly earnings announcement on Monday, August 8th 2022. View our earnings forecast for MediPha...
Who are MediPharm Labs' key executives?
MediPharm Labs' management team includes the following people: Mr. Keith Strachan , Co-Founder & Pres Mr. Patrick McCutcheon , Founder Mr. Greg...
Who are some of MediPharm Labs' key competitors?
Some companies that are related to MediPharm Labs include Celadon Pharmaceuticals (CEL) , FSD Pharma (HUGE) , Meta Growth (META) , Khiron Life...
What other stocks do shareholders of MediPharm Labs own?
Based on aggregate information from My MarketBeat watchlists, some companies that other MediPharm Labs investors own include Cronos Group (CRON) ,...
What is MediPharm Labs' stock symbol?
MediPharm Labs trades on the Toronto Stock Exchange (TSX) under the ticker symbol "LABS."
How do I buy shares of MediPharm Labs?
Shares of LABS and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadia...
About MediPharm Labs
MediPharm Labs Corp., together with its subsidiaries, produces and sells pharmaceutical-grade cannabis oil and concentrates, and advance derivative products in Canada and Australia. It formulates, processes, packages, and distributes cannabis extracts and cannabinoid-based products.
MediPharm Labs (TSE:LABS) Frequently Asked Questions
2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for MediPharm Labs in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" MediPharm Labs stock.
TSE:LABS
He has as $6.75 as a speculative buy. He thinks sales continue to track along and thinks this down turn may be the best thing for them. When it comes to CBD oil production everything is being produced in North America. The industry as a whole has been consolidating, but he is still going to wait before buying in as whole.
What is Medipharm Labs Corp stock symbol?
Medipharm Labs Corp is a Canadian stock, trading under the symbol LABS-T on the Toronto Stock Exchange (LABS-CT). It is usually referred to as TSX:LABS or LABS-T
Is Medipharm Labs Corp a buy or a sell?
In the last year, there was no coverage of Medipharm Labs Corp published on Stockchase.
Is Medipharm Labs Corp a good investment or a top pick?
Medipharm Labs Corp was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Medipharm Labs Corp.
Why is Medipharm Labs Corp stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
Is Medipharm Labs Corp worth watching?
0 stock analysts on Stockchase covered Medipharm Labs Corp In the last year. It is a trending stock that is worth watching.
What is a MediPharm Labs license?
MediPharm Labs’ Cannabis Drug Licence and expertise qualifies and positions the Company to supply clinical trial material, assist in investigation protocol and provide regulatory support for multiple trialsThree initial proposed clinical trials will evaluate the effectiveness of proprietary THC and CBD drug candidates for multiple indications including Pain, Insomnia associated with Major Depression, and Uremic Pruritus. BARRIE, Ontario, June 21, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TS
What is MediPharm's white label?
Through its wholesale and white label platforms, MediPharm formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets.
When is the MediPharm Q1 2021 conference call?
Q1 2021 FINANCIAL RESULTS CONFERENCE CALL MediPharm executive management team will host a conference call and audio webcast to discuss the results and outlook for the three-month period ended March 31, 2021 on Monday, May 17, 2021, at 8:30 a.m. eastern time.
Does MediPharm have to update its forward-looking statements?
Except as required by law, MediPharm Labs assumes no obligation to update the forward-look ing statements of beliefs, opinions, projections, or other factors, should they change. CONTACT: For further information, please contact: Laura Lepore, VP, Investor Relations and Communications Telephone: 416-913-7425 ext.
What is MediPharm Labs?
Through its wholesale and white label platforms, MediPharm Labs formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets.
When is the MediPharm Q1 2021 conference call?
Q1 2021 FINANCIAL RESULTS CONFERENCE CALL MediPharm executive management team will host a conference call and audio webcast to discuss the results and outlook for the three-month period ended March 31, 2021 on Monday, May 17, 2021, at 8:30 a.m. eastern time.
Signals & Forecast
There are few to no technical positive signals at the moment. The Medipharm Labs Corp stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average.
Support, Risk & Stop-loss
Medipharm Labs Corp finds support from accumulated volume at $0.15 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
Is Medipharm Labs Corp stock A Buy?
Medipharm Labs Corp holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star. This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
Transparency is our policy. Learn how it impacts everything we do
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
How we make money
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management.
How we use your personal data
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
How we approach editorial content
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view.
Is Medical Marijuana Really A Slippery Slope? CVSI Distribution Agreement with GNC
The Best Daily Overview Of The Cannabis Space CV Sciences Announces New Distribution Agreement with GNC. $CVSI Massachusetts cannabis prices continue to fall Kentucky GOP Sen. Damon Thayer: "Medical cannabis is a slippery slope for recreational marijuana.”
The Week In Cannabis: Stocks Down, Republican Legalization Bill, Germany, Uruguay, Earnings, New ETF And More
Below is a recap of the main news related to the cannabis industry and markets for the week of November 15, 2021. Contents
The Week In Cannabis: PharmaCann Could IPO, Tilray & MedMen, First Black CEO At Major Public Co. And More
Below is a recap of the main news related to the cannabis industry and markets for the week of August 20, 2021. Contents
